UNIVERSITY OF IOWA HUNTINGTON'S DISEASE CENTER FOR EXCELLENCE

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 爱荷华州大学已被美国亨廷顿病协会（HDSA）指定为亨廷顿病（HD）卓越中心。 HDSA家庭服务和研究卓越中心是HDSA认可的具有亨廷顿病专业知识的医疗机构。 HDSA中心提供了一个多学科的方法来治疗这种复杂的，无情的进展性疾病。 服务包括，但不限于，神经病学，精神病学，语言，物理和职业治疗，遗传咨询和基因检测以及社会工作和区域转介。 HDSA卓越中心计划的成功是无与伦比的。 亨廷顿病卓越中心是加强临床研究的最新模式，旨在以协调的方式开展基础和临床研究。 中心活动的集中地点对于实现这种协调至关重要。 将医疗服务与研究机会相结合是治疗这种复杂疾病的有效方法，目前还没有有效的治疗方法。 随着这些中心的发展，预计临床试验的数量将随之增加，从而加强寻找减缓疾病进展的方法并最终找到治愈方法的努力。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The University of Iowa has been designated a Huntington's Disease (HD) Center for Excellence by the Huntington's Disease Society of America (HDSA). HDSA Centers of Excellence for Family Services and Research are medical facilities that have been recognized by HDSA as having expertise in Huntington's disease. HDSA Centers provide a multidisciplinary approach to the treatment of this complex, relentlessly progressive disease. Services include, but are not limited to, neurology, psychiatry, speech, physical and occupational therapys, genetic counseling and genetic testing as well as social work and regional referrals. The success of HDSA's Centers of Excellence program has been unparalleled. The Huntington's Disease Center of Excellence is the newest model for enhancing clinical research, formed to conduct basic and clinical research in a coordinated manner. A centralized location for Center activities is critical in making this coordination possible. Combining medical services with research opportunities serves as an efficient approach to this complex disease, for which no effective treatment currently exists. As the Centers develop it is expected that an increase in the number of clinical trials will follow, enhancing efforts at finding ways to slow down disease progression, and ultimately finding a cure.